Correlation Between Smith Nephew and Nemaura Medical
Can any of the company-specific risk be diversified away by investing in both Smith Nephew and Nemaura Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smith Nephew and Nemaura Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smith Nephew SNATS and Nemaura Medical, you can compare the effects of market volatilities on Smith Nephew and Nemaura Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smith Nephew with a short position of Nemaura Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smith Nephew and Nemaura Medical.
Diversification Opportunities for Smith Nephew and Nemaura Medical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Smith and Nemaura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Smith Nephew SNATS and Nemaura Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nemaura Medical and Smith Nephew is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smith Nephew SNATS are associated (or correlated) with Nemaura Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nemaura Medical has no effect on the direction of Smith Nephew i.e., Smith Nephew and Nemaura Medical go up and down completely randomly.
Pair Corralation between Smith Nephew and Nemaura Medical
If you would invest 2,418 in Smith Nephew SNATS on December 29, 2024 and sell it today you would earn a total of 377.00 from holding Smith Nephew SNATS or generate 15.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Smith Nephew SNATS vs. Nemaura Medical
Performance |
Timeline |
Smith Nephew SNATS |
Nemaura Medical |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Smith Nephew and Nemaura Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Smith Nephew and Nemaura Medical
The main advantage of trading using opposite Smith Nephew and Nemaura Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smith Nephew position performs unexpectedly, Nemaura Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nemaura Medical will offset losses from the drop in Nemaura Medical's long position.Smith Nephew vs. Beyond Air | Smith Nephew vs. PAVmed Series Z | Smith Nephew vs. Clearpoint Neuro | Smith Nephew vs. LivaNova PLC |
Nemaura Medical vs. Neuropace | Nemaura Medical vs. CVRx Inc | Nemaura Medical vs. Orthofix Medical | Nemaura Medical vs. Artivion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |